Vendors benefit from patent extension exclusivity and are able to hold onto their market share in the worldwide proton pump inhibitors market thanks to pharmacological reformulation.
One of the main causes boosting the Proton Pump Inhibitors Market is pharmacological reformulation. The efficacy of medications is increased by drug delivery methods such transdermal patches, extended-release (ER) formulations, and orally disintegrating tablets, either by improving patient compliance or by enhancing the drug's bioavailability.
The option to get patent term extensions, which can stall the release of generic versions of marketed medications, is also presented by their reformulation. The opportunity to titrate the dose in accordance with individual needs can be opened up by the reformulation of solid dosage forms like tablets.
Read more @ https://creativeedge16.blogspot.com/2022/07/proton-pump-inhibitors-market-size.html
